Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects.
Purpose: Tolvaptan is a selective vasopressin V2 receptor antagonist that can be given orally once daily for treatment of clinically significant hypervolemic and euvolemic hyponatremia (US and Europe) or extracellular volume expansion despite taking other diuretics (Japan). In vitro studies indicate...
| Published in: | European Journal of Clinical Pharmacology Vol. 68; no. 2; pp. 207 - 212 |
|---|---|
| Main Authors: | , , |
| Format: | research tables/charts randomized controlled trial Journal Article |
| Published: |
Springer Nature
Feb2012
|
| Online Access: | View this record in EBSCOhost |